Skip to main content
Top
Published in: Journal of Natural Medicines 3/2019

01-06-2019 | Alogliptin | Original Paper

Salacia chinensis stem extract and its thiosugar sulfonium constituent, neokotalanol, improves HbA1c levels in ob/ob mice

Authors: Masakazu Kobayashi, Junji Akaki, Yasuyo Yamaguchi, Hiroo Yamasaki, Kiyofumi Ninomiya, Yutana Pongpiriyadacha, Masayuki Yoshikawa, Osamu Muraoka, Toshio Morikawa

Published in: Journal of Natural Medicines | Issue 3/2019

Login to get access

Abstract

The antidiabetic effects of a hot water extract of the stems of Salacia chinensis (SCE) were evaluated in vivo in ob/ob mice (genetically obese hyperglycemic mice). Administration of dietary feed containing 0.20 and 0.50% of SCE for 23 days to ob/ob mice significantly suppressed the elevation of both blood glucose and HbA1c levels, without significantly changing body weight and food intake. To characterize the antidiabetic effects of the thiosugar sulfonium constituent neokotalanol (1), which has potent α-glucosidase inhibitory activity, we performed a similar in vivo study. HbA1c levels were significantly suppressed in ob/ob mice after the administration of dietary feed containing 0.0003% of neokotalanol (1) for 20 days. These results indicate that SCE and neokotalanol (1) are potential leads for the development of novel antidiabetic agents.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lindström P (2007) The physiology of obese-hyperglycemic mice [ob/ob mice]. Sci World J 7:666–685CrossRef Lindström P (2007) The physiology of obese-hyperglycemic mice [ob/ob mice]. Sci World J 7:666–685CrossRef
2.
go back to reference Wang B, Chandrasekera PC, Pippin JJ (2014) Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr Diab Rev 10:131–145CrossRef Wang B, Chandrasekera PC, Pippin JJ (2014) Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr Diab Rev 10:131–145CrossRef
3.
go back to reference Betz B, Conway BR (2016) An update on the use of animal models in diabetic nephropathy research. Curr Diab Rep 16:18CrossRef Betz B, Conway BR (2016) An update on the use of animal models in diabetic nephropathy research. Curr Diab Rep 16:18CrossRef
4.
go back to reference Mayer J, Russel E, Bates MV, Dickie MM (1953) Metabolic, nutritional and endocrine studies of the hereditary obesity-diabetes syndrome of mice and mechanism of its development. Metabolism 2:9–21PubMed Mayer J, Russel E, Bates MV, Dickie MM (1953) Metabolic, nutritional and endocrine studies of the hereditary obesity-diabetes syndrome of mice and mechanism of its development. Metabolism 2:9–21PubMed
5.
go back to reference Garthwaite TL, Martinson DR, Tseng LF, Hagen TC, Menahan LA (1980) A longitudinal hormonal profile of the genetically obese mice. Endocrinology 107:671–676CrossRef Garthwaite TL, Martinson DR, Tseng LF, Hagen TC, Menahan LA (1980) A longitudinal hormonal profile of the genetically obese mice. Endocrinology 107:671–676CrossRef
6.
go back to reference Xie J-T, Mehendale SR, Li X, Quigg R, Wang X, Wang C-Z, Wu JA, Aung HH, Rue PA, Bell GI, Yuan C-S (2005) Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta 1740:319–325CrossRef Xie J-T, Mehendale SR, Li X, Quigg R, Wang X, Wang C-Z, Wu JA, Aung HH, Rue PA, Bell GI, Yuan C-S (2005) Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta 1740:319–325CrossRef
7.
go back to reference Lee Y-S, Cha B-Y, Saito K, Yamakawa H, Choi S-S, Yamaguchi K, Yonezawa T, Teruya T, Nagai K, Woo J-T (2010) Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice. Biochem Pharmcol 79:1674–1683CrossRef Lee Y-S, Cha B-Y, Saito K, Yamakawa H, Choi S-S, Yamaguchi K, Yonezawa T, Teruya T, Nagai K, Woo J-T (2010) Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice. Biochem Pharmcol 79:1674–1683CrossRef
8.
go back to reference Huang S-L, Yu R-T, Gong J, Feng Y, Dai Y-L, Hu F, Hu Y-H, Tao Y-D, Leng Y (2012) Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia 55:1469–1481CrossRef Huang S-L, Yu R-T, Gong J, Feng Y, Dai Y-L, Hu F, Hu Y-H, Tao Y-D, Leng Y (2012) Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia 55:1469–1481CrossRef
9.
go back to reference Matsuda H, Yoshikawa M, Morikawa T, Tanabe G, Muraoka O (2005) Antidiabetogenic constituents from Salacia species. J Tradit Med 22(Suppl 1):145–153 Matsuda H, Yoshikawa M, Morikawa T, Tanabe G, Muraoka O (2005) Antidiabetogenic constituents from Salacia species. J Tradit Med 22(Suppl 1):145–153
10.
go back to reference Yoshikawa M, Morikawa T, Matsuda H, Tanabe G, Muraoka O (2002) Absolute stereostructure of potent α-glucosidase inhibitor, salacinol, with unique thiosugar sulfonium sulfate inner salt structure from Salacia reticulata. Bioorg Med Chem 10:1547–1554CrossRef Yoshikawa M, Morikawa T, Matsuda H, Tanabe G, Muraoka O (2002) Absolute stereostructure of potent α-glucosidase inhibitor, salacinol, with unique thiosugar sulfonium sulfate inner salt structure from Salacia reticulata. Bioorg Med Chem 10:1547–1554CrossRef
11.
go back to reference Yoshikawa M, Pongpiriyadacha Y, Kishi A, Kageura T, Wang T, Morikawa T, Matsuda H (2003) Biological activities of Salacia chinensis originating in Thailand: the quality evaluation guided by α-glucosidase inhibitory activity. Yakugaku Zasshi 123:871–880CrossRef Yoshikawa M, Pongpiriyadacha Y, Kishi A, Kageura T, Wang T, Morikawa T, Matsuda H (2003) Biological activities of Salacia chinensis originating in Thailand: the quality evaluation guided by α-glucosidase inhibitory activity. Yakugaku Zasshi 123:871–880CrossRef
12.
go back to reference Morikawa T, Akaki J, Ninomiya K, Kinouchi E, Tanabe G, Pongpiriyadacha Y, Yoshikawa M, Muraoka O (2015) Salacinol and related analogs: new leads for type 2 diabetes therapeutic candidates from the Thai traditional natural medicine Salacia chinensis. Nutrients 7:1480–1493CrossRef Morikawa T, Akaki J, Ninomiya K, Kinouchi E, Tanabe G, Pongpiriyadacha Y, Yoshikawa M, Muraoka O (2015) Salacinol and related analogs: new leads for type 2 diabetes therapeutic candidates from the Thai traditional natural medicine Salacia chinensis. Nutrients 7:1480–1493CrossRef
13.
go back to reference Muraoka O, Morikawa T, Miyake S, Akaki J, Ninomiya K, Pongpiriyadacha Y, Yoshikawa M (2011) Quantitative analysis of neosalacinol and neokotalanol, another two potent α-glucosidase inhibitors from Salacia species, by LC–MS with ion pair chromatography. J Nat Med 65:142–148CrossRef Muraoka O, Morikawa T, Miyake S, Akaki J, Ninomiya K, Pongpiriyadacha Y, Yoshikawa M (2011) Quantitative analysis of neosalacinol and neokotalanol, another two potent α-glucosidase inhibitors from Salacia species, by LC–MS with ion pair chromatography. J Nat Med 65:142–148CrossRef
14.
go back to reference Muraoka O, Xie W, Osaki S, Kagawa A, Tanabe G, Amer MFA, Minematsu T, Morikawa T, Yoshikawa M (2010) Characteristic alkaline catalyzed degradation of kotalanol, a potent α-glucosidase inhibitor isolated from Ayurvedic traditional medicine Salacia reticulata, leading to anhydroheptitols: another structural proof. Tetrahedron 66:3717–3722CrossRef Muraoka O, Xie W, Osaki S, Kagawa A, Tanabe G, Amer MFA, Minematsu T, Morikawa T, Yoshikawa M (2010) Characteristic alkaline catalyzed degradation of kotalanol, a potent α-glucosidase inhibitor isolated from Ayurvedic traditional medicine Salacia reticulata, leading to anhydroheptitols: another structural proof. Tetrahedron 66:3717–3722CrossRef
15.
go back to reference Muraoka O, Morikawa T, Miyake S, Akaki J, Ninomiya K, Yoshikawa M (2010) Quantitative determination of potent α-glucosidase inhibitors, salacinol and kotalanol, in Salacia species using liquid chromatography-mass spectrometry. J Pharm Biomed Anal 52:770–773CrossRef Muraoka O, Morikawa T, Miyake S, Akaki J, Ninomiya K, Yoshikawa M (2010) Quantitative determination of potent α-glucosidase inhibitors, salacinol and kotalanol, in Salacia species using liquid chromatography-mass spectrometry. J Pharm Biomed Anal 52:770–773CrossRef
16.
go back to reference Xie W, Tanabe G, Akaki J, Morikawa T, Ninomiya K, Minematsu T, Yoshikawa M, Wu X, Muraoka O (2011) Isolation, structure identification and SAR studies on thiosugar sulfonium salts, neosalaprinol and neoponkoranol, as potent α-glucosidase inhibitors. Bioorg Med Chem 19:2015–2022CrossRef Xie W, Tanabe G, Akaki J, Morikawa T, Ninomiya K, Minematsu T, Yoshikawa M, Wu X, Muraoka O (2011) Isolation, structure identification and SAR studies on thiosugar sulfonium salts, neosalaprinol and neoponkoranol, as potent α-glucosidase inhibitors. Bioorg Med Chem 19:2015–2022CrossRef
17.
go back to reference Xie W, Tanabe G, Xu J, Wu X, Morikawa T, Yoshikawa M, Muraoka O (2013) Research progress of synthesis and structure-activity relationship studies on sulfonium-type α-glucosidase inhibitors isolated from Salacia genus plants. Mini Rev Org Chem 10:141–159CrossRef Xie W, Tanabe G, Xu J, Wu X, Morikawa T, Yoshikawa M, Muraoka O (2013) Research progress of synthesis and structure-activity relationship studies on sulfonium-type α-glucosidase inhibitors isolated from Salacia genus plants. Mini Rev Org Chem 10:141–159CrossRef
18.
go back to reference Akaki J, Morikawa T, Miyake S, Ninomiya K, Okada M, Tanabe G, Pongpiriyadacha Y, Yoshikawa M, Muraoka O (2014) Evaluation of Salacia species as anti-diabetic natural resources based on quantitative analysis of eight sulphonium constituents: a new class of α-glucosidase inhibitors. Phytochem Anal 25:544–550CrossRef Akaki J, Morikawa T, Miyake S, Ninomiya K, Okada M, Tanabe G, Pongpiriyadacha Y, Yoshikawa M, Muraoka O (2014) Evaluation of Salacia species as anti-diabetic natural resources based on quantitative analysis of eight sulphonium constituents: a new class of α-glucosidase inhibitors. Phytochem Anal 25:544–550CrossRef
19.
go back to reference Kobayashi M, Akaki J, Yamashita K, Morikawa T, Ninomiya K, Yoshikawa M, Muraoka O (2010) Suippressive effect of the tablet containing Salacia chinensis extract on postprandial blood glucose. Jpn Pharmacol Ther 38:545–550 Kobayashi M, Akaki J, Yamashita K, Morikawa T, Ninomiya K, Yoshikawa M, Muraoka O (2010) Suippressive effect of the tablet containing Salacia chinensis extract on postprandial blood glucose. Jpn Pharmacol Ther 38:545–550
20.
go back to reference Kobayashi M, Akaki J, Yamaguchi Y, Yamasaki H, Morikawa T, Ninomiya K, Yoshikawa M, Muraoka O (2016) Safety evaluation of long term and excess intake of the tablet containing hot water extract of Salacia hinensis. Jpn Pharmacol Ther 44:399–408 Kobayashi M, Akaki J, Yamaguchi Y, Yamasaki H, Morikawa T, Ninomiya K, Yoshikawa M, Muraoka O (2016) Safety evaluation of long term and excess intake of the tablet containing hot water extract of Salacia hinensis. Jpn Pharmacol Ther 44:399–408
21.
go back to reference Yamada K, Sato-Mito N, Nagata J, Umegak K (2008) Health claim evidence requirements in Japan. J Nutr 138:1192S–1198SCrossRef Yamada K, Sato-Mito N, Nagata J, Umegak K (2008) Health claim evidence requirements in Japan. J Nutr 138:1192S–1198SCrossRef
22.
go back to reference Tsutani K, Takuma H (2008) Regulatory sciences in herbal medicines and dietary supplements. Yakugaku Zasshi 128:867–880CrossRef Tsutani K, Takuma H (2008) Regulatory sciences in herbal medicines and dietary supplements. Yakugaku Zasshi 128:867–880CrossRef
23.
go back to reference Nagata J, Yamada K (2008) Foods with health claims in Japan. Food Sci Technol Res 14:519–524CrossRef Nagata J, Yamada K (2008) Foods with health claims in Japan. Food Sci Technol Res 14:519–524CrossRef
24.
go back to reference Shimizu M (2012) Functional food in Japan: current status and future of gut-modulating food. J Food Drug Anal 20(Suppl 1):213–216 Shimizu M (2012) Functional food in Japan: current status and future of gut-modulating food. J Food Drug Anal 20(Suppl 1):213–216
25.
go back to reference Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M, Yamakado M, Yatomi Y, Ohashi H (2012) Committee on the standardization of diebetes mellitus-related laboratory testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan diabetes society to national glycohemoglobin standardization program values. J Diabetes Investig 3:39–40CrossRef Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, Tominaga M, Oikawa S, Noda M, Kawamura T, Sanke T, Namba M, Hashiramoto M, Sasahara T, Nishio Y, Kuwa K, Ueki K, Takei I, Umemoto M, Murakami M, Yamakado M, Yatomi Y, Ohashi H (2012) Committee on the standardization of diebetes mellitus-related laboratory testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan diabetes society to national glycohemoglobin standardization program values. J Diabetes Investig 3:39–40CrossRef
Metadata
Title
Salacia chinensis stem extract and its thiosugar sulfonium constituent, neokotalanol, improves HbA1c levels in ob/ob mice
Authors
Masakazu Kobayashi
Junji Akaki
Yasuyo Yamaguchi
Hiroo Yamasaki
Kiyofumi Ninomiya
Yutana Pongpiriyadacha
Masayuki Yoshikawa
Osamu Muraoka
Toshio Morikawa
Publication date
01-06-2019
Publisher
Springer Singapore
Keyword
Alogliptin
Published in
Journal of Natural Medicines / Issue 3/2019
Print ISSN: 1340-3443
Electronic ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-019-01311-w

Other articles of this Issue 3/2019

Journal of Natural Medicines 3/2019 Go to the issue